Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens
Open Access
- 1 September 1985
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 86 (1) , 141-150
- https://doi.org/10.1111/j.1476-5381.1985.tb09444.x
Abstract
1 The prejunctional inhibitory effects of clonidine and 6-fluoronoradrenaline (6-FNA) have been evaluated in the isolated prostatic segment of the rat vas deferens, against the twitch response evoked by low frequency (0.1 Hz) field stimulation. 2 The inhibitory potency of 6FNA was significantly increased in the presence of cocaine (1 μM) or pargyline (10 μM), but was not modified in the vas deferens from rats pretreated with reserpine when the endogenous levels of noradrenaline (NA) were decreased by 97%. Clonidine was significantly more potent than 6-FNA as an inhibitory agonist, and the potency of clonidine was not modified after cocaine, pargyline or reserpine. 3 The α2-adrenoceptor blocking agent idazoxan, was a competitive antagonist against the inhibitory effects of clonidine under all experimental conditions. In contrast, the only antagonism shown by idazoxan against the inhibitory effects of 6-FNA was in the presence of cocaine (1 μM), and this antagonist effect of idazoxan was not concentration-related. 4 Low concentrations of 6-FNA caused concentration-dependent facilitatory effects on the twitch response, which were significantly greater after treatment with idazoxan (1 μM) in reserpine-treated vas deferens. These facilitatory effects of 6-FNA were always observed in the presence of prazosin (300 nM) and also after treatment of the preparations with phenoxybenzamine (10 μM), a concentration which abolished the inhibitory actions of both clonidine and 6-FNA. The facilitatory effects on the twitch response induced by low concentrations of 6-FNA are therefore unlikely to be due to either α1- or α2-adrenoceptor stimulation. 5 In conclusion, the failure of idazoxan to block the inhibitory effects of 6-FNA, while exerting a potent competitive antagonism of clonidine-induced inhibitory effects, supports the proposal that α2-adrenoceptors may in fact be subdivided into two subclasses, involving imidazoline and phenylethylamine recognition sites.This publication has 35 references indexed in Scilit:
- Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferensPublished by Elsevier ,2002
- Inhibitory effects of α,β-methylene ATP on nerve-mediated contractions of the nictitating membrane in reserpinised catsEuropean Journal of Pharmacology, 1985
- An investigation of the actions of the calcium entry facilitator bay K 864 on the rat vas deferensEuropean Journal of Pharmacology, 1984
- Inhibition of excitatory junction potentials in guinea-pig vas deferens by α, β-methylene-ATP: Further evidence for ATP and noradrenaline as cotransmittersEuropean Journal of Pharmacology, 1984
- Dissociation of presynaptic α2-adrenoceptors following prazosin administration: Presynaptic effect of prazosinEuropean Journal of Pharmacology, 1983
- Structure-activity relationships for 2-substituted imidazoles as .alpha.2-adrenoceptor antagonistsJournal of Medicinal Chemistry, 1982
- Cardiovascular effects of 2-(NN-dimethyl)amino-6,7-dihydroxy-1,2,3,4 tetrahydronaphthalene in pithed rats: differential antagonism by yohimbine and prazosinJournal of Pharmacy and Pharmacology, 1980
- Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of α-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slicesEuropean Journal of Pharmacology, 1980
- RAPID CONCURRENT AUTOMATED FLUORIMETRIC ASSAY OF NORADRENALINE, DOPAMINE, 3, 4‐DIHYDROXYPHENYLACETIC ACID, HOMOVANILLIC ACID AND 3‐METHOXYTYRAMINE IN MILLIGRAM AMOUNTS OF NERVOUS TISSUE AFTER ISOLATION ON SEPHADEX G10Journal of Neurochemistry, 1977
- Pharmacological characterisation of the presynaptic α-adrenoceptor in the rat vas deferensEuropean Journal of Pharmacology, 1977